{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Latest Clinical Trials Involving Targeted Therapies for NSCLC

Activity Steps

1 Activity
2 Take Test 3Certificate

Purpose of Activity

To provide information on recent trials designed to treat non-small cell lung cancer (NSCLC) with targeted therapies.

Learning Objectives

After completing this continuing education activity you will be able to:

Identify findings from recent clinical trials of targeted therapies for non-small cell lung cancer.

Disclosures

All authors, faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • KY-BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.







Planner
Test Code: OT0417
Published: Apr 2017
Expires: 12/31/2026
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Richard Simoneaux
Categories: Cancer , Oncology
Specialties: Oncology
Topics: Cancer , Lung , Targeted Therapy